Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Cholecalciferol + risedronate sodium by Dongkook Pharmaceutical for Osteoporosis: Likelihood of Approval
Cholecalciferol + risedronate sodium is under clinical development by Dongkook Pharmaceutical and currently in Phase I for Osteoporosis. According to...
Data Insights
Cholecalciferol + risedronate sodium by Dongkook Pharmaceutical for Post Menopausal Osteoporosis: Likelihood of Approval
Cholecalciferol + risedronate sodium is under clinical development by Dongkook Pharmaceutical and currently in Phase I for Post Menopausal Osteoporosis....